PHM-27 (human) belongs to the peptide family derived from VIP/PHM precursors, containing residues suited for receptor-binding exploration. Conformational adaptability enables structural modeling of neuroendocrine regulatory pathways. Sequence motifs affect solubility and folding patterns. Research applies it to biosynthesis mapping and peptide-ligand interaction studies.
CAT No: V1314
CAS No:87403-73-4
Synonyms/Alias:PHM-27 (human);87403-73-4;118025-43-7;Heptacosapeptide, Porcine Intestinal;PHM-27 human;Peptide Histidine Methionine;AKOS024456933;DA-66674;PD079251;L-Methioninamide,l-histidyl-L-alanyl-L-a-aspartylglycyl-L-valyl-L-phenylalanyl-L-threonyl-L-seryl-L-a-aspartyl-L-phenylalanyl-L-seryl-L-Lysyl-L-Leucyl-L-Leucylglycyl-L-glutaminyl-l-leucyl-l-seryl-l-al;
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. TMEM16F and dynamins control expansive plasma membrane reservoirs
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.